Bergen, 03 May 2022
Reference is made to the stock exchange announcement by Lifecare AS (the"Company") on 20 April 2022 regarding the share issue resolved by the board ofdirectors as part of the previously agreed consideration from Lifecare AS toacquire Lifecare Laboratories GmbH (formely named Pfützner Science and HealthGmbH). The share capital increase has now been registered with the NorwegianRegister of Business Enterprises (Nw. Foretaksregisteret). The new share capitalof the Company is NOK 39,896,409.20, divided into 99,741,023 shares, each with anominal value of NOK 0.4
This is Lifecare Lifecare is a Bergen-based technology company developing a miniaturizedimplantable long-term sensor for correct and continuous monitoring of bloodsugar in people with diabetes. The Company's patented technology also has thepotential for use in various biomarkers. Lifecare AS is listed on EuronextGrowth (LIFE).
Further information: Joacim Holter, CEO, Lifecare AS, firstname.lastname@example.org,+47 40 05 90 40
This information is subject to the disclosure requirements pursuant to Section5-12 the Norwegian Securities Trading Act. This stock exchange announcement waspublished by Kine Hereid, Investor Relations at Lifecare AS, on 03 May 2022 at16:00 CET.